PHARMACEUTICAL MARKET RESEARCH REPORTS
Industry Standard Research – ISR Reports – is a full-service pharmaceutical market research company operating exclusively in the life sciences industry and a sister company of BioProcess Online. Their syndicated and custom market research capabilities enable their customers to make smarter, more informed business decisions. You’ll find links to their pharmaceutical market syndicated research reports below.
ISR's market research reports are produced using direct feedback from decision-makers, which enables ISR to provide data on topics that, until now, were only attainable through custom research. With rigorous screening criteria and methodologies that include surveys, in-depth phone interviews, and focus groups, ISR gathers actionable information that is immediately applicable to their customers. Each report is available to purchase online and you may also download free preview files. If you have any questions, please feel free to email info@ISRreports.com.
TRENDS AND MARKET OUTLOOKS
Sterile Injectable Drug Product Manufacturing Market Outlook: 2023-2028
This report explores which delivery formats drug innovators are using in their pipelines and portfolios, how likely innovators are to outsource manufacturing based on delivery device, and how these proportions will shift over the next five years.
Cell & Gene Therapies Manufacturing Market Outlook (2nd Ed.)
Current market dynamics and outlook of the cell & gene therapies contract manufacturing space and predictions on what the marketplace will look like in 2028. Key stats include the volume of cell therapies/gene therapies in sponsors’ pipelines, corresponding manufacturing activities that will be outsourced, average outsourcing expenditure on cell and/or gene therapies, and number of CDMOs required to complete the work.
Central Lab Benchmarking & Market Dynamics (2nd Ed.)
This report will help both study sponsors and providers answer a number of questions relevant to selecting and evaluating central lab service providers. For the purpose of this report, “central lab” is defined as a vendor that supplies specimen collection kits, logistics services, safety alerts, and a wide variety of laboratory testing services as well as providing lab reports to investigators.
Emerging Biopharma Perspective On Highly Potent API Manufacturing Market
An overview of the current market dynamics for high containment manufacturing from the perspective of HPAPI manufacturing decision-makers at sponsor organizations at small and midsize biopharmaceutical companies and their predictions on what the market will look like in five years.
Bioprocessing Market Outlook: 2022-2027
This report provides an overview of the current market dynamics for bioprocessing and predictions on its next five years. It also offers insight into the CDMO selection process and the main drivers of sponsor satisfaction on outsourced bioprocessing projects.
Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (4th Edition)
This market research report goes into depth on the manufacturing aspect of biosimilars. Manufacturing these complex products in a cost efficient manner will be a critical component to successfully commercializing biosimilars and the anticipated boom.
Pharmaceutical Excipient Market Overview and Outlook
This market research report offers readers the opportunity to gain insight into the biopharmaceutical excipient market and where it’s heading. Remaining aware of market dynamics and expected changes will enable readers to better make key decisions regarding excipient use and to help identify where competitive advantages may be gained.
Development vs Commercial Outsourced Manufacturing Practices: Biologics
This market research report explores how the decision-making process differs among drug innovators outsourcing development activities from those outsourcing commercial manufacturing when it comes to CMO/CDMO selection criteria, use patterns, preferences and perceived leadership.
QUALITY BENCHMARKING AND SERVICE PROVIDER PERFORMANCE
Gene Therapy CDMO Benchmarking
This research provides gene therapy companies and contract manufacturers with the latest insights, outsourcing trends, and best practices reported within the specific domain, as well as benchmarks for assessing service quality among the 14 CDMOs featured in the report.
Biologic API CDMO Benchmarking (8th Ed.)
This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CDMO service quality.
Biologic Drug Product CDMO Benchmarking (5th Ed.)
This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality.
Biologic API CDMO Benchmarking For New & Emerging Pharma
This report is based on responses from 45 people involved in outsourced large molecule API projects over the last 18 months. It will help new/emerging pharma companies make informed CDMO selections, and help CDMOs better understand how they are perceived.
Bioanalytical Labs Market Dynamics and Service Provider Performance
Sponsors can use this report to evaluate their lab selection process. Bioanalytical labs can use it to learn how their company performs against competitors. Topics covered include lab selection and perceptions, lab performance, and lab service quality profiles.
DEPARTMENT MODELS AND STRUCTURES
The CMC Function At Emerging Pharma
This report provides an in-depth exploration of the role and function of Chemistry, Manufacturing, and Controls (CMC) throughout the stages of product development, spanning preclinical, clinical, and commercialization phases. A specific emphasis is placed on the configuration of the CMC function within virtual and small biopharmaceutical companies.
The CMC Function: Best Practices and Optimization
ISR interviewed 15 CMC professionals at 14 Top 50 pharmaceutical and biotechnology companies, as well as one company outside the Top 50 to better understand the Chemistry Manufacturing and Controls function throughout the preclinical, clinical, and commercialization phases of the product development process.
How Market Research Can Inform CDMO Selection
Empower decision-makers while helping CDMOs tailor their strategies to better meet sponsor needs through reliable benchmark data, grounded in rigorous methodology.
Slide Down The Funnel To Stand Out
Explore the tremendous value of understanding brand position in the biopharmaceutical market and how research into strategic placement, target audience, and more can help companies stand out.
The Value Of Strategic Outsourcing Relationships
In observing the strategic partnerships between CDMOs and drug developers, learn which characteristics experts say developers should prioritize when evaluating contract manufacturers.
Results From The 2023 CDMO Leadership Awards
After evaluating 72 contract manufacturers on 23 different performance metrics, see who was a recipient of the 2023 CDMO Leadership Awards.
Tracking The Evolution Of CDMO Selection Criteria
Year-over-year variation exists in the criteria respondents prioritize in an outsourced manufacturer. Consider these five metrics when choosing a provider for biological drug substance manufacturing.